Century Therapeutics to Participate in the Piper Sandler 35th Annual Healthcare Conference

Century Therapeutics

PHILADELPHIA, PA — Century Therapeutics (NASDAQ: IPSC), a leading-edge biotechnology company, has announced its participation in the upcoming Piper Sandler 35th Annual Healthcare Conference. The conference, a key event in the healthcare and investment calendar, is set to take place on Tuesday, November 28, 2023.

Members of the Century Therapeutics management team will feature prominently in a fireside chat at 10:00 AM ET. This open discussion format allows for an intimate, in-depth conversation about the company’s innovative strategies, future plans, and current market trends.

For those unable to attend the live event, a replay will be made available on the “Events & Presentations” page in the “Investors” section of the Company’s official website. This replay will offer interested parties the opportunity to catch up on any missed content at their convenience, as it will remain accessible for 90 days following the events.

This announcement comes at a time when Century Therapeutics has been making significant strides in its field. As investors and industry insiders are well aware, the company has been at the forefront of developing innovative cell therapies for cancer, harnessing the power of stem cells to provide patients with viable, long-term treatment options.

The Piper Sandler Annual Healthcare Conference serves as a platform for healthcare companies and investors to connect, discuss, and shape the future of the industry. Investors, analysts, and interested parties are encouraged to tune into the fireside chat to gain deeper insights into Century Therapeutics’ ongoing initiatives, strategic focus, and how these tie into the larger picture of the rapidly evolving healthcare landscape.

READ:  NST and Valley Bank Launch Smart Safe Program for Cash-Intensive Businesses

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.